Free Trial

CochLear (CHEOY) Stock Forecast & Price Target

CochLear logo
$99.64 +0.06 (+0.06%)
As of 09/12/2025 03:48 PM Eastern

CochLear - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
0
Hold
2
Buy
1

Based on 3 Wall Street analysts who have issued ratings for CochLear in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 3 analysts, 2 have given a hold rating, and 1 has given a strong buy rating for CHEOY.

Consensus Price Target

N/A

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for CHEOY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for CochLear and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CHEOY Analyst Ratings Over Time

TypeCurrent Forecast
9/14/24 to 9/14/25
1 Month Ago
8/15/24 to 8/15/25
3 Months Ago
6/16/24 to 6/16/25
1 Year Ago
9/15/23 to 9/14/24
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
Hold
2 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Consensus RatingModerate BuyModerate BuyHoldHold

CHEOY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CHEOY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

CochLear Stock vs. The Competition

TypeCochLearMedical CompaniesS&P 500
Consensus Rating Score
2.67
2.78
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted UpsideN/A17,489.59% Upside10.72% Upside
News Sentiment Rating
Neutral News

See Recent CHEOY News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
8/11/2025Zacks Research
0 of 5 stars
 UpgradeHold
6/18/2025UBS Group
4 of 5 stars
L. Sutcliffe
Not Rated
UpgradeHoldStrong-Buy
1/16/2025The Goldman Sachs Group
3 of 5 stars
D. Thillainathan
Not Rated
Initiated CoverageNeutral
8/16/2024Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 07:31 PM ET.


CHEOY Forecast - Frequently Asked Questions

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CochLear in the last twelve months. There are currently 2 hold ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CHEOY shares.

According to analysts, CochLear's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Over the previous 90 days, CochLear's stock had 2 upgrades by analysts.

CochLear has been rated by research analysts at UBS Group, and Zacks Research in the past 90 days.

Analysts like CochLear less than other "medical" companies. The consensus rating score for CochLear is 2.67 while the average consensus rating score for "medical" companies is 2.78. Learn more on how CHEOY compares to other companies.


This page (OTCMKTS:CHEOY) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners